SMTL ID : 3l9n.1

crystal structure of PKAB3 (pka triple mutant V123A, L173M, Q181K) with compound 27

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.00 Å

Oligo State

hetero-oligomer

Ligands

1 x L9N: (2S)-N~1~-[5-(1H-INDAZOL-5-YL)-1,3,4-THIADIAZOL-2-YL]-3-(4-METHYLPHENYL)PROPANE-1,2-DIAMINE(Non-covalent)

L9N.1: 17 residues within 4Å: Chain A: L.50, G.51, F.55, V.58, A.71, K.73, V.105, M.121, E.122, Y.123, A.124, E.128, E.171, N.172, M.174, T.184, D.185 12 PLIP interactions: 12 interactions with chain A Hydrophobic interactions: A:L.50, A:F.55, A:V.105, A:M.121, A:T.184 Hydrogen bonds: A:K.73, A:K.73, A:A.124, A:N.172, A:D.185, A:D.185, A:D.185

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Zeng, Q. et al., Azole-based inhibitors of AKT/PKB for the treatment of cancer. Bioorg.Med.Chem.Lett. (2010)

Release Date

2011-01-19

Peptides

cAMP-dependent protein kinase catalytic subunit alpha: A
cAMP-dependent protein kinase inhibitor alpha: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
C

cAMP-dependent protein kinase catalytic subunit alpha

cAMP-dependent protein kinase inhibitor alpha

Related Entries With Identical Sequence